OFFICE OF THE EXECUTIVE VICE CHANCELLOR
OFFICE OF THE VICE CHANCELLOR FOR RESEARCH
OFFICE OF THE VICE CHANCELLOR FOR HEALTH SCIENCES
OFFICE OF THE VICE CHANCELLOR FOR MARINE SCIENCES
March 26, 2020
ALL ACADEMICS AND STAFF AT UC SAN DIEGO (including UC San Diego Health
Sciences and Health)
SUBJECT: || Continuity of Research|
We appreciate the care and speed with which researchers have modified
their work in order to prioritize the health of all by reducing on-site
activity and on-site staff while maintaining essential research.
Essential staff members remain on-site to maintain our research
infrastructure, and researchers off-site are continuing virtual data
collection and analysis, writing proposals, reports and publications,
and continuing research through remote technologies. Many members of our
research community have turned their expertise and energy toward finding
solutions to the COVID-19 emergency and are demonstrating the
determination and innovation that have made UC San Diego one of the top
research universities in the nation.
We will continue to post updates at
https://blink.ucsd.edu/research/COVID-19-research.html, and will host
Research Town Halls via webinar on April 9 and 15 (see below for more
information). UC San Diego requirements and resources are highlighted
ON-SITE RESEARCH ACTIVITY AND PERSONNEL:
HUMAN SUBJECTS RESEARCH MUST RESTRICT IN-PERSON CONTACT to protect the
health of participants, researchers, and research personnel.
- ALL RESEARCH must move as much activity as possible to a remote
- On-site activity must be minimized, and should be restricted to
critical activities, in accordance with campus notice of 3/17
- Researchers should revisit plans for approved on-site research to
ensure that personnel on-site have been kept at a minimum – generally,
no more than 1 person per research space or no more than 15% of normal
on-site staffing levels;
- Students are not considered essential personnel, and are to be
conducting on-site activity only by exception;
- CDC guidelines for social distancing and sanitary work spaces and
facilities must be followed in all labs and research spaces.
EXTERNALLY-FUNDED CONTRACTS AND GRANTS are subject to specific agency
guidelines; guidelines vary and researchers must work closely with their
MSOs and Project Officers to manage grants.
- In-person human research is restricted to clinical trials involving
FDA-regulated interventions such as an investigational drug or device
treating serious or life-threatening diseases, and human subjects
research directed to identification or development of clinical responses
to COVID-19/SARS-CoV-2 (such as vaccines or treatments). Whenever
possible, study visits for clinical trials should use telephonic,
computer or video encounters.
- Studies and research participant encounters for other human subject
research may continue for currently enrolled participants using
telephonic, computer or video encounters, but must otherwise be
postponed and new participant enrollment suspended until the Governor’s
Order and University limitations are lifted.
• IRB guidance is available at https://irb.ucsd.edu/Home.FWx.
COVID-19 RELATED RESEARCH is an important way that UC San Diego can
contribute to the international response to the COVID-19 pandemic.
TO KEEP YOU INFORMED, HEAR YOUR CONCERNS AND ANSWER YOUR QUESTIONS, we
will be hosting Research Town Halls via webinar weekly in April. The
first webinars are scheduled for April 9 and 15 from 12:30-2:00pm. We
invite you to submit questions in advance to focus our discussion and
will take questions during the webinar. Information and registration
links are available at https://blink.ucsd.edu/research/COVID-19-research.html.
- Individual agencies continue to issue new guidance that is available
on the OCGA website listed below and includes information about proposal
and reporting deadlines, allowable costs, managing awards and
- All expenses related to COVID-19 should be tracked closely, to help
in the preparation of future applications for supplemental funding and
university efforts to seek disaster recovery funding.
- Grant accounts should not be overspent. Overages will have to be
covered by the use of PI discretionary funds and/ or department or
- Grantees should contact program managers to ensure they are fully
aware of the challenges PI’s are facing and the likely costs for which
supplemental funding will be required.
- Sponsor guidance, FAQs, and a summary matrix are available at
We of course are ready to answer any questions, and offer any assistance
we can, at any time.
Elizabeth H. Simmons|
Executive Vice Chancellor
Sandra A. Brown
Vice Chancellor for Research
David A. Brenner
Vice Chancellor for Health Sciences
Margaret S. Leinen
Vice Chancellor for Marine Sciences